GLP-1 RAs：新陈代谢医学的最新动力。

IF 0.6 Q4 NURSING

NURSE PRACTITIONER Pub Date : 2024-08-01 Epub Date: 2024-07-25 DOI:10.1097/01.NPR.0000000000000216

Evan S Drake, Adriane B Marino, Jenna D Theroux, Kaitlin Roberts

{"title":"GLP-1 RAs：新陈代谢医学的最新动力。","authors":"Evan S Drake, Adriane B Marino, Jenna D Theroux, Kaitlin Roberts","doi":"10.1097/01.NPR.0000000000000216","DOIUrl":null,"url":null,"abstract":"Abstract: In the last decade, the glucagon-like peptide-1 (GLP-1) receptor agonist (RA) drug class has revolutionized treatment for type 2 diabetes mellitus and some of its comorbidities, including obesity and cardiovascular disease. Continued advancements in the GLP-1 RA space show clinical promise for patients, though challenges-including barriers to care such as drug expense and availability-exist. This article provides an overview of available GLP-1 RAs and their mechanisms of action, indications, adverse reactions, and risks, providing practical pearls for providers along the way.","PeriodicalId":51812,"journal":{"name":"NURSE PRACTITIONER","volume":null,"pages":null},"PeriodicalIF":0.6000,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"GLP-1 RAs: The newest powerhouse in metabolic medicine.\",\"authors\":\"Evan S Drake, Adriane B Marino, Jenna D Theroux, Kaitlin Roberts\",\"doi\":\"10.1097/01.NPR.0000000000000216\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Abstract: In the last decade, the glucagon-like peptide-1 (GLP-1) receptor agonist (RA) drug class has revolutionized treatment for type 2 diabetes mellitus and some of its comorbidities, including obesity and cardiovascular disease. Continued advancements in the GLP-1 RA space show clinical promise for patients, though challenges-including barriers to care such as drug expense and availability-exist. This article provides an overview of available GLP-1 RAs and their mechanisms of action, indications, adverse reactions, and risks, providing practical pearls for providers along the way.\",\"PeriodicalId\":51812,\"journal\":{\"name\":\"NURSE PRACTITIONER\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.6000,\"publicationDate\":\"2024-08-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"NURSE PRACTITIONER\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1097/01.NPR.0000000000000216\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/7/25 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q4\",\"JCRName\":\"NURSING\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"NURSE PRACTITIONER","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1097/01.NPR.0000000000000216","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/7/25 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"NURSING","Score":null,"Total":0}

引用次数: 0

摘要

摘要：在过去十年中，胰高血糖素样肽-1（GLP-1）受体激动剂（RA）类药物彻底改变了 2 型糖尿病及其一些合并症（包括肥胖症和心血管疾病）的治疗方法。GLP-1 RA 领域的不断进步为患者带来了临床希望，但同时也存在着挑战，包括药物费用和可用性等治疗障碍。本文概述了现有的 GLP-1 RA 及其作用机制、适应症、不良反应和风险，并为医疗服务提供者提供了实用的指南。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

GLP-1 RAs: The newest powerhouse in metabolic medicine.

Abstract: In the last decade, the glucagon-like peptide-1 (GLP-1) receptor agonist (RA) drug class has revolutionized treatment for type 2 diabetes mellitus and some of its comorbidities, including obesity and cardiovascular disease. Continued advancements in the GLP-1 RA space show clinical promise for patients, though challenges-including barriers to care such as drug expense and availability-exist. This article provides an overview of available GLP-1 RAs and their mechanisms of action, indications, adverse reactions, and risks, providing practical pearls for providers along the way.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

NURSE PRACTITIONER NURSING-

CiteScore

0.90

自引率

0.00%

发文量

183

期刊介绍： With a circulation of 20,000, The Nurse Practitioner is the leading monthly source for clinical, practical, cutting-edge information for advanced practice nurses and other primary care clinicians. Each issue presents peer-reviewed articles that range from clinical topics and research to political and practice issues. In addition, The Nurse Practitioner provides regular features, columns, continuing education, staff development education, and more.